Immunizations (adult): Clinical sciences

Immunizations (adult): Clinical sciences

Watch later

Watch later

Esophageal disorders: Pathology review
Spinal muscular atrophy
Hypopituitarism: Pathology review
Cardiomyopathies: Pathology review
Atopic dermatitis
Cystic fibrosis: Pathology review
Anatomy clinical correlates: Viscera of the gastrointestinal tract
Neonatal hepatitis
Zollinger-Ellison syndrome
Carcinoid syndrome
Prebiotics and probiotics
Approach to hepatic masses: Clinical sciences
Anemia in pregnancy: Clinical sciences
Intraamniotic infection: Clinical sciences
Urinary tract infections and kidney stones in pregnancy: Clinical sciences
Fetal growth restriction: Clinical sciences
Hypokalemia
Approach to hypokalemia: Clinical sciences
Urinary tract infection (pediatrics): Clinical sciences
Approach to bleeding disorders (coagulopathy): Clinical sciences
Approach to bleeding disorders (platelet dysfunction): Clinical sciences
Approach to bleeding disorders (thrombocytopenia): Clinical sciences
Congestive heart failure: Clinical sciences
Ventilation-perfusion ratios and V/Q mismatch
Anatomic and physiologic dead space
Diffusion-limited and perfusion-limited gas exchange
Bartonella henselae (Cat-scratch disease and Bacillary angiomatosis)
Heme synthesis disorders: Pathology review
Thrombotic microangiopathy: Clinical sciences
Disseminated intravascular coagulation: Clinical sciences
Spinal fractures: Clinical sciences
Approach to traumatic brain injury (pediatrics): Clinical sciences
Hypothermia: Clinical sciences
Approach to biliary colic: Clinical sciences
Upper respiratory tract infections: Clinical sciences
Airway obstruction: Clinical sciences
Rhinovirus
Approach to neurodevelopmental disorders: Clinical sciences
Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD): Clinical sciences
Approach to benzodiazepine and barbiturate use, intoxication, and overdose: Clinical sciences
Approach to dysarthria or dysphagia: Clinical sciences
Myasthenia gravis: Clinical sciences
Anatomy clinical correlates: Glossopharyngeal (CN IX), vagus (X), spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Spinal cord disorders: Pathology review
Calcium channel blockers
Gastroesophageal varices: Clinical sciences
Acneiform skin disorders: Pathology review
Angelman syndrome
Klinefelter syndrome
Maternal D alloimmunization (management): Clinical sciences
WAGR syndrome
Glycogen storage disease type I
Perimenopause, menopause, and primary ovarian insufficiency: Clinical sciences
West Nile virus
Approach to hematochezia (pediatrics): Clinical sciences
Esophageal perforation: Clinical sciences
Approach to precocious puberty: Clinical sciences
Immunizations (adult): Clinical sciences
Cutaneous squamous cell carcinoma: Clinical sciences
Approach to postoperative abdominal pain: Clinical sciences
Vulvar skin disorders (benign): Clinical sciences
Placental abruption: Clinical sciences
Approach to increased intracranial pressure: Clinical sciences
Intra-abdominal abscess: Clinical sciences
Approach to a fever in the returned traveler: Clinical sciences
Infectious mononucleosis: Clinical sciences
Infectious gastroenteritis: Clinical sciences
Graves disease: Clinical Sciences
Gastritis: Clinical sciences
Surgical site infection: Clinical sciences
Bladder injury: Clinical sciences
Spinal infection and abscess: Clinical sciences
Uterine atony: Clinical sciences
Fecal impaction: Clinical sciences
Benign prostatic hypertrophy and prostate cancer: Clinical sciences
Approach to penetrating chest injury: Clinical sciences
Immune thrombocytopenia: Clinical sciences
Aortic stenosis: Clinical sciences
Approach to non-healing wounds: Clinical sciences
Approach to pneumoperitoneum and peritonitis (perforated viscus): Clinical sciences
Spontaneous bacterial peritonitis: Clinical sciences
Approach to ascites: Clinical sciences
Ischemic colitis: Clinical sciences
Hepatic encephalopathy: Clinical sciences
Tuberculosis (extrapulmonary and latent): Clinical sciences
Approach to back pain: Clinical sciences
Atrial fibrillation and atrial flutter: Clinical sciences
Approach to convulsive status epilepticus: Clinical sciences
Herpes zoster infection (shingles): Clinical sciences
Abdominal aortic aneurysm: Clinical sciences
Parkinson disease and dementia with Lewy bodies: Clinical sciences
Cytomegalovirus (CMV), parvovirus B19, varicella zoster, and toxoplasmosis infection in pregnancy: Clinical sciences
Developmental milestones (toddler): Clinical sciences
Approach to proteinuria (pediatrics): Clinical sciences
Approach to blunt cerebrovascular injury: Clinical sciences
Coxsackievirus
Local anesthetics
General anesthetics
Approach to lower airway obstruction (pediatrics): Clinical sciences
Approach to interstitial lung disease (diffuse parenchymal lung disease): Clinical sciences
Approach to a cough (acute): Clinical sciences
Chronic bronchitis
Bronchiectasis
Human parainfluenza viruses
Cytoskeleton and elastin disorders: Pathology review
Disorders of fatty acid metabolism: Pathology review
Long QT syndrome and Torsade de pointes
Reye syndrome
Bacteroides fragilis
BK virus (Hemorrhagic cystitis)
Post-transplant lymphoproliferative disorders (NORD)
Guillain-Barré syndrome: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Immunizations, also known as vaccines, stimulate the immune system to produce antibodies against specific microorganisms. These antibodies not only disable pathogens but also remain in the body to provide long-term immunity, decrease the likelihood of infection, and decrease the severity of infection.

Adult vaccinations are commonly administered during annual wellness visits according to the patient’s age. However, some special considerations such as international travel, pregnancy, and immunocompromised status may alter the usual sequence of immunization.

Now, if your patient presents for routine vaccination, first assess their age. For patients 19 to 26 years old, offer the one- or two-dose COVID-19 series. This vaccine protects against variants of the SARS-CoV-2 virus, which can cause acute nose, lung, or throat infections, and sometimes respiratory distress, viral pneumonia, and even myocarditis. If previously vaccinated against COVID-19, give them a single dose as a booster.

Next, patients should receive their influenza vaccine, also known as the flu shot. This annual vaccine helps to protect from influenza, an acute respiratory illness that can progress to viral pneumonia.

Moving on, if your patient has not already received their completed Hepatitis B and HPV vaccinations, administer these as well. Hepatitis B immunizations are given in a multi-dose series and help protect against liver disease caused by acute or chronic hepatitis B infection.

On the other hand, the two- or three-dose HPV vaccine series protects against the human papillomavirus. This virus can cause genital warts as well as various forms of genital and throat cancers.

Next up is the Tdap vaccine, which stands for Tetanus, Diphtheria, and activated Pertussis. And you guessed it, it protects against the bacteria Clostridium tetani, Corynebacterium diphtheriae, and Bordetella pertussis. As a reminder, Clostridium tetani produces the tetanus toxin that affects neuromuscular transmission and results in painful muscle contractions and spasms.

Corynebacterium diphtheriae produces the diphtheria toxin that affects mucous membranes of the throat and nose and can lead to severe upper airway obstruction and respiratory distress. This condition is also known as diphtheria.

Lastly, Bordetella pertussis produces the pertussis toxin that typically results in specific paroxysmal coughing called whooping cough. Adult patients should receive a Tdap vaccine every ten years. Alternatively, after the first Tdap immunization, they can receive the Td vaccine every ten years as a booster. Keep in mind Td vaccination protects against tetanus and diphtheria only.

Let’s take a break with a clinical pearl!! Besides the usual booster every 10 years, you can give Tdap or Td vaccines in special circumstances, like pregnancy and wound management.

For each pregnancy, patients should receive one Tdap vaccine.

For wound management, patients with severe wounds should have a Tdap or Td vaccine if their last immunization was over five years ago. However, patients with minor clean wounds should only have a Tdap or Td vaccine if it has been longer than ten years since their last booster.

Patients with a wound of any severity who are uncertain when their last booster was received should get the Tdap or Td vaccine prophylactically. Moreover, all previously unvaccinated patients with wounds should receive the Tdap vaccine instead of Td.

Okay, let’s go back to vaccines for your 19 to 26-year-old patient. Next up is the RSV vaccine which protects from respiratory syncytial virus, an acute respiratory illness. While the viral infection is usually mild in younger adults, in older adults with chronic medical conditions and infants, it can progress to respiratory distress. To protect against RSV transmission to infants, it is recommended to give one dose of the vaccine to patients who are 32 to 36 weeks pregnant during the fall or winter.

Moving on to the VAR vaccine. This vaccine protects against primary varicella-zoster infection, commonly called chickenpox, which causes an itchy generalized vesicular rash and can lead to pneumonia or encephalitis. Chickenpox is most commonly seen in children and teenagers but can also occur in adults so give this vaccine series to nonpregnant adults with no history of previous varicella-zoster infection.

Next up is the MenACWY vaccine, which protects against the A, C, W, and Y subtypes of the bacteria Neisseria meningitidis, all of which can cause meningitis and lead to seizures or death. High-risk patients include college students ages 16 to 23, travelers to endemic regions, and immunocompromised patients with asplenia or HIV.

Okay, now that we’ve reviewed vaccines for healthy 19 to 26-year-olds, let’s take a look at vaccines needed for this same age range but who are immunocompromised.

First up is the RZV vaccine which protects against herpes zoster, a rash of painful vesicles on one side of the body, more commonly known as shingles. Shingles results from the reactivation of a previous varicella-zoster infection. It typically affects younger adults with compromised immune systems or older adults. Administer this vaccine series to patients with compromised immune systems, such as patients with HIV or AIDS.

Sources

  1. "Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2024" Morb Mortal Wkly Rep (2024)
  2. "Adult Vaccination" Am Fam Physician (2022)
  3. "Adult Immunization Schedule by Age" CDC (2023)
  4. "Adult Immunization Schedule by Medical Condition and Other Indication" CDC (2023)
  5. "Vaccine-Preventable Adult Diseases" CDC (2022)